Æȷοì
Jeffrey W. Cooney
Á¦¸ñ
Àοë
Àοë
¿¬µµ
Top-down suppression deficit underlies working memory impairment in normal aging
A Gazzaley, JW Cooney, J Rissman, M D'esposito
Nature neuroscience 8 (10), 1298-1300, 2005
11352005
Top-down enhancement and suppression of the magnitude and speed of neural activity
A Gazzaley, JW Cooney, K McEvoy, RT Knight, M D'esposito
Journal of cognitive neuroscience 17 (3), 507-517, 2005
6092005
Functional interactions between prefrontal and visual association cortex contribute to top-down modulation of visual processing
A Gazzaley, J Rissman, J Cooney, A Rutman, T Seibert, W Clapp, ...
Cerebral cortex 17 (suppl_1), i125-i135, 2007
3342007
Hierarchical cognitive control deficits following damage to the human frontal lobe
D Badre, J Hoffman, JW Cooney, M D'esposito
Nature neuroscience 12 (4), 515-522, 2009
3132009
Neurological disorders and the structure of human consciousness
JW Cooney, MS Gazzaniga
Trends in Cognitive Sciences 7 (4), 161-165, 2003
1372003
Age-related deficits in component processes of working memory.
A Gazzaley, MA Sheridan, JW Cooney, M D'esposito
Neuropsychology 21 (5), 532, 2007
1312007
Neuropsychiatric issues in Parkinson¡¯s disease
JW Cooney, M Stacy
Current neurology and neuroscience reports 16 (5), 1-13, 2016
962016
Is the prefrontal cortex necessary for delay task performance? Evidence from lesion and FMRI data
M D'esposito, JW Cooney, A Gazzaley, SEB Gibbs, BR Postle
Journal of the International Neuropsychological Society 12 (2), 248-260, 2006
952006
Telemedicine and Deep brain stimulation-Current practices and recommendations
VD Sharma, D Safarpour, SH Mehta, N Vanegas-Arroyave, D Weiss, ...
Parkinsonism & Related Disorders 89, 199-205, 2021
172021
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson¡¯s disease psychosis: an expert consensus
KJ Black, H Nasrallah, S Isaacson, M Stacy, R Pahwa, CH Adler, G Alva, ...
CNS spectrums 23 (6), 402-413, 2018
122018
Initial clinical outcome with bilateral, dual-target deep brain stimulation trial in Parkinson disease using summit RC+ S
KT Mitchell, SL Schmidt, JW Cooney, WM Grill, J Peters, S Rahimpour, ...
Neurosurgery 91 (1), 132-138, 2022
72022
Mindfulness based stress reduction in people with Parkinson's disease and their care partners
D Shah-Zamora, AM Allen, L Rardin, M Ivancic, K Durham, P Hickey, ...
Complementary Therapies in Clinical Practice 43, 101377, 2021
72021
Corticobasal syndrome in a man with Gaucher disease type 1: expansion of the understanding of the neurological spectrum
KC Potnis, LB Flueckinger, SM DeArmey, RN Alcalay, JW Cooney, ...
Molecular Genetics and Metabolism Reports 17, 69-72, 2018
52018
Viewpoint on Milestones for Fellowship Training in Movement Disorders
Movement Disorders, 2022
22022
Levodopa inhalation powder in a patient with persistent asthma
C Gillette, JW Cooney, CB Sisson, N Rockich-Winston, CJ Perry, ...
Parkinsonism & Related Disorders 78, 44-45, 2020
12020
The Benchmark Clinic: A Comprehensive Care Model for People with Parkinson's Disease
S Mantri, K Mitchell, A Allen, N Bukhari-Parlakturk, N Calakos, J Cooney, ...
MOVEMENT DISORDERS 35, S550-S551, 2020
2020
ÇöÀç ½Ã½ºÅÛÀÌ ÀÛµ¿µÇÁö ¾Ê½À´Ï´Ù. ³ªÁß¿¡ ´Ù½Ã ½ÃµµÇØ ÁÖ¼¼¿ä.
ÇмúÀÚ·á 1–16